Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)

Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)

US Patent 7790407 · Granted Sep 7, 2010

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptors (CARs), compositions and methods thereof2025
Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositi2024
Chimeric antigen receptors (CARs), compositions and methods thereof2023
Chimeric antigen receptors (CARs), compositions and methods of use thereof2023
Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and me2021
Chimeric antigen receptors (CARs), targeting hematologic malignancies, compositi2019
Method for expansion of stem cells and the use of such cells2016
Isolation and growth of stem cells from hemangiomas2013